Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes of Stockholders??? Equity (Deficit) (Unaudited)

v3.25.1
Condensed Consolidated Statements of Changes of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Total
Conversion of notes payable to Common Stock
Conversion of Series A Preferred Stock to Common Stock
Series A Preferred Stock
Series A Preferred Stock
Conversion of Series A Preferred Stock to Common Stock
Common Stock
Common Stock
Conversion of notes payable to Common Stock
Common Stock
Conversion of Series A Preferred Stock to Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of notes payable to Common Stock
Additional Paid-in Capital
Conversion of Series A Preferred Stock to Common Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2023       0   1,389,884              
Beginning Balance at Dec. 31, 2023 $ (41,786,850)     $ 0   $ 139     $ 77,004,714     $ 0 $ (118,791,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation 530,655               530,655        
Vesting of RSUs (in shares)           43,922              
Vesting of RSUs 0         $ 4     (4)        
Exercise of warrants (in shares)           158,333              
Exercise of warrants 1,339,654         $ 16     1,339,638        
Net loss (72,838,936)                       (72,838,936)
Ending Balance (in shares) at Mar. 31, 2024       0   1,592,139              
Ending Balance at Mar. 31, 2024 (112,755,477)     $ 0   $ 159     78,875,003     0 (191,630,639)
Beginning Balance (in shares) at Dec. 31, 2023       0   1,389,884              
Beginning Balance at Dec. 31, 2023 (41,786,850)     $ 0   $ 139     77,004,714     0 (118,791,703)
Ending Balance (in shares) at Dec. 31, 2024       35,034   9,761,895              
Ending Balance at Dec. 31, 2024 (20,397,413)     $ 4   $ 976     233,342,188     (42,229) (253,698,352)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation 312,679               312,679        
Vesting of RSUs (in shares)           59,348              
Vesting of RSUs 0         $ 6     (6)        
Conversion of Stock (in shares)         (15,188)   1,805,392 16,018,211          
Conversion of Stock   $ 2,870,573 $ 0   $ (2)   $ 181 $ 1,601   $ 2,870,392 $ (1,599)    
At the Market (ATM) share offering (in shares)           7,488,822              
At the Market (ATM) share offering 19,438,121         $ 749     19,437,372        
Earnout shares (contingent) 6,864,729               6,864,729        
Other (in shares)           19,520              
Other 0         $ 2     (2)        
Net loss (7,567,187)                       (7,567,187)
Ending Balance (in shares) at Mar. 31, 2025       19,846   35,153,188              
Ending Balance at Mar. 31, 2025 $ 1,521,502     $ 2   $ 3,515     $ 262,825,753     $ (42,229) $ (261,265,539)